Companies
Bloom Energy
solid-oxide fuel-cell and electrolyser stacks that reform biogas/biomethane directly to hydrogen; a $25 billion Brookfield financing pact (June 2026), 400 MW Centrica data-center supply and a 2.8 GW Oracle commitment scale the platform.
- Country
- United States
- Ticker
- NYSE:BE
Commercial
Solid-oxide reforming
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| biofuels-bioenergy | ✓ | ✓ | ✓ | ✓ |
Regulatorsepaademenea
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Partnership | $25 billion Brookfield financing pact (June 2026) | energydigital.com · enkiai.com · investor.bloomenergy.com |
| Capacity | 2 GW annual production capacity targeted by end of 2026; company footprint can support up to 5 GW annual capacity | finance.biggo.com · utilitydive.com |
| Certification | CARB Distributed Generation Certification (various models), American Bureau of Shipping (ABS) Type Approval for marine modules, and CE marking for European market | ww2.arb.ca.gov · bloomenergy.com |
| Regulatory approval | Recognized as topping-cycle cogeneration facilities by FERC; qualifying as minor air pollution sources under Clean Air Act compared to major-source gas turbines | ferc.gov · techtimes.com |
| Production site | United States (manufacturing) | energydigital.com · investor.bloomenergy.com |
| Headcount | More than 2,000 employees worldwide | energydigital.com · investor.bloomenergy.com |
| Revenue | $1.065 billion for Q2 2026; full-year 2026 guidance raised to $3.9 billion – $4.2 billion | finance.biggo.com · investor.bloomenergy.com |
Independent sources: energydigital.com · enkiai.com · ferc.gov · finance.biggo.com · techtimes.com · utilitydive.com · ww2.arb.ca.gov
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Hydrogen fuel from biomass | biofuels-bioenergy | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.